Journal of Clinical Oncology, Vol 5, 1410-1418, Copyright © 1987 by American Society of Clinical Oncology

ARTICLES

Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trial

KK Fu, TL Phillips, IJ Silverberg, C Jacobs, DR Goffinet, C Chun, MA Friedman, M Kohler, K McWhirter and SK Carter

Between 1978 and 1984, the Northern California Oncology Group (NCOG) conducted a randomized trial to study the efficacy of combined radiotherapy (RT) and chemotherapy (CT) for stage III or IV inoperable head and neck cancer. One hundred four patients were randomized to receive: (1) RT alone, or (2) RT plus CT. RT consisted of 7,000 cGy to the involved areas and 5,000 cGy to uninvolved neck at 180 cGy/fraction, five fractions/wk. CT consisted of bleomycin, 5 U intravenously (IV), twice weekly during RT, followed by bleomycin, 15 U IV, and methotrexate, 25 mg/m2 IV weekly for 16 weeks after completion of RT. Fifty-one patients in the RT alone group and 45 in the combined treatment group were evaluable. The local-regional complete response (CR) rate was 45% v 67% (P = .056); the 2-year local-regional control rate, including salvage surgery, was 26% v 64% (P = .001); and the incidence of distant metastasis was 24% v 38% (P greater than .25), for the RT alone and RT plus CT groups, respectively. The relapse-free survival curves were significantly different (P = .041), favoring the combined treatment. However, the survival curves were not significantly different (P = .16). Patient compliance to maintenance CT was poor. Bleomycin significantly increased the acute radiation mucositis, although the difference in late normal tissue toxicity was not statistically significant. Thus, bleomycin and concurrent RT produced a more favorable CR rate, local-regional control rate, and relapse-free survival, but the difference in survival was not statistically significant.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. Merlano Alternating chemotherapy and radiotherapy in locally advanced head and neck cancer: an alternative? Oncologist, February 1, 2006; 11(2): 146 - 151. [Abstract] [Full Text] [PDF]

				J. Bernier and J. S. Cooper Chemoradiation after Surgery for High-Risk Head and Neck Cancer Patients: How Strong Is the Evidence? Oncologist, March 1, 2005; 10(3): 215 - 224. [Abstract] [Full Text] [PDF]

				A.S. Garden, J. Harris, E.E. Vokes, A.A. Forastiere, J.A. Ridge, C. Jones, E.M. Horwitz, B.S. Glisson, L. Nabell, J.S. Cooper, et al. Preliminary Results of Radiation Therapy Oncology Group 97-03: A Randomized Phase II Trial of Concurrent Radiation and Chemotherapy for Advanced Squamous Cell Carcinomas of the Head and Neck J. Clin. Oncol., July 15, 2004; 22(14): 2856 - 2864. [Abstract] [Full Text] [PDF]

				J. Aguilar-Ponce, M. Granados-Garcia, V. Villavicencio, A. Poitevin-Chacon, D. Green, A. Duenas-Gonzalez, A. Herrera-Gomez, K. Luna-Ortiz, A. Alvarado, H. Martinez-Said, et al. Phase II trial of gemcitabine concurrent with radiation for locally advanced squamous cell carcinoma of the head and neck Ann. Onc., February 1, 2004; 15(2): 301 - 306. [Abstract] [Full Text] [PDF]

				D. J. Adelstein, Y. Li, G. L. Adams, H. Wagner Jr, J. A. Kish, J. F. Ensley, D. E. Schuller, and A. A. Forastiere An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer J. Clin. Oncol., January 1, 2003; 21(1): 92 - 98. [Abstract] [Full Text] [PDF]

				A. Eisbruch, D. S. Shewach, C. R. Bradford, J. F. Littles, T. N. Teknos, D. B. Chepeha, L. J. Marentette, J. E. Terrell, N. D. Hogikyan, L. A. Dawson, et al. Radiation Concurrent With Gemcitabine for Locally Advanced Head and Neck Cancer: A Phase I Trial and Intracellular Drug Incorporation Study J. Clin. Oncol., February 1, 2001; 19(3): 792 - 799. [Abstract] [Full Text] [PDF]

				G. Calais, M. Alfonsi, E. Bardet, C. Sire, T. Germain, P. Bergerot, B. Rhein, J. Tortochaux, P. Oudinot, and P. Bertrand Randomized Trial of Radiation Therapy Versus Concomitant Chemotherapy and Radiation Therapy for Advanced-Stage Oropharynx Carcinoma J Natl Cancer Inst, December 15, 1999; 91(24): 2081 - 2086. [Abstract] [Full Text] [PDF]

				A. S. Garden, B. S. Glisson, K. K. Ang, W. H. Morrison, S. M. Lippman, R. M. Byers, F. Geara, G. L. Clayman, D. M. Shin, D. L. Callender, et al. Phase I/II Trial of Radiation With Chemotherapy ""Boost"" for Advanced Squamous Cell Carcinomas of the Head and Neck: Toxicities and Responses J. Clin. Oncol., August 1, 1999; 17(8): 2390 - 2390. [Abstract] [Full Text] [PDF]

				D. M. Brizel, M. E. Albers, S. R. Fisher, R. L. Scher, W. J. Richtsmeier, V. Hars, S. L. George, A. T. Huang, and L. R. Prosnitz Hyperfractionated Irradiation with or without Concurrent Chemotherapy for Locally Advanced Head and Neck Cancer N. Engl. J. Med., June 18, 1998; 338(25): 1798 - 1804. [Abstract] [Full Text] [PDF]

				E. E. Vokes, R. R. Weichselbaum, S. M. Lippman, and W. K. Hong Head and Neck Cancer N. Engl. J. Med., January 21, 1993; 328(3): 184 - 194. [Full Text]

				M. C. Weissler, S. Melin, S. L. Sailer, B. F. Qaqish, J. G. Rosenman, and H. C. Pillsbury III Simultaneous Chemoradiation in the Treatment of Advanced Head and Neck Cancer Arch Otolaryngol Head Neck Surg, August 1, 1992; 118(8): 806 - 810. [Abstract] [PDF]